Rib-X Pharmaceuticals Inc. landed the year s third-largest private round of financing, reeling in $51 million in a Series B placement of preferred stock.(BioWorld Today)

Rib-X Pharmaceuticals Inc. landed the year s third-largest private round of financing, reeling in $51 million in a Series B placement of preferred stock.(BioWorld Today)